Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Leslie B Lilly"'
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 29, Iss 8, Pp 417-422 (2015)
BACKGROUND: The literature regarding post-transplant lymphoproliferative disorder (PTLD) in liver transplant recipients (LTRs) is limited.
Externí odkaz:
https://doaj.org/article/180ca09e4f1c4bcc95b554604873687a
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 28, Iss 1, Pp 41-44 (2014)
BACKGROUND: Hepatitis B immunoglobulin (HBIG) given in combination with a nucleos(t)ide analogue has reduced the rate of recurrent hepatitis B virus (HBV) infection following liver transplantation (LT); however, the most effective protocol remains un
Externí odkaz:
https://doaj.org/article/84508563422d484c8b167efb09f72ba7
Publikováno v:
Canadian Journal of Gastroenterology, Vol 27, Iss 3, Pp 131-136 (2013)
BACKGROUND: Hepatitis C virus (HCV) infection remains the leading indication for liver transplantation (LT) worldwide. Recurrent hepatitis C following LT is universal, and significant fibrosis (SF, Metavir fibrosis stage ≥2) apparent on protocol bi
Externí odkaz:
https://doaj.org/article/a91cd025221e408f8d74c593362a1faf
Autor:
Shihao Ma, Barry B. Rubin, Douglas S. Lee, Leslie B. Lilly, Xueqi Wang, Osvald Nitski, Kymberly D. Watt, Amirhossein Azhie, Bo Wang, Sumeet K. Asrani, Josh Levitsky, Mamatha Bhat, Fakhar Ali Qazi-Arisar
Publikováno v:
The Lancet: Digital Health, Vol 3, Iss 5, Pp e295-e305 (2021)
Summary: Background: Survival of liver transplant recipients beyond 1 year since transplantation is compromised by an increased risk of cancer, cardiovascular events, infection, and graft failure. Few clinical tools are available to identify patients
Autor:
Nabiha Faisal, MD, FCPS, Eric M. Yoshida, Marc Bilodeau, Philip Wong, Mang Ma, Kelly W. Burak, Bandar Al-Judaibi, Eberhard L. Renner, Leslie B. Lilly
Publikováno v:
Annals of Hepatology, Vol 13, Iss 5, Pp 525-532 (2014)
Introduction. Hepatitis C (HCV) continues to be the leading indication for liver transplantation (LT). Sustained virological response (SVR) rates to pegylated interferon (PEG-IFN) and ribavirin (RBV) therapy for recurrent HCV in Genotype 1 (G1) LT re
Externí odkaz:
https://doaj.org/article/844f8a7d86274a84abe445e26c0ea2e5
Autor:
Jordan J. Feld, Fernanda Q. Onofrio, Alnoor Ramji, Alexander Wong, Brian Conway, Joshua Booth, Izza Sattar, Sergio Borgia, Curtis Cooper, Leslie B. Lilly, Marie-Louise Vachon, Samuel Lee, Heidy Morales
Publikováno v:
Clinical Infectious Diseases. 72:e799-e805
Background Despite the current highly effective therapies with direct-acting antiviral agents (DAAs), some patients with chronic hepatitis C virus (HCV) infection still do not achieve sustained virological response (SVR) and require retreatment. Sofo
Autor:
Eric M. Yoshida, M.D., M.H.Sc., FR.C.P.C., Leslie B. Lilly, Paul J. Marotta, Andrew L. Mason, Marc Bilodeau, Marc Vaillancourt
Publikováno v:
Annals of Hepatology, Vol 12, Iss 2, Pp 282-293 (2013)
The transition from regular use of cyclosporine to the newer calcineurin-inhibitors, such as tacrolimus, has been suggested as a contributing factor to the “era effect” of worsening outcomes of post-transplant HCV recurrence. This retrospective m
Externí odkaz:
https://doaj.org/article/ab0668c251ca4617b36aa2d3510123d3
Autor:
Markus Selzner, Aloysious Aravinthan, Waleed Fateen, Leslie B. Lilly, Zita Galvin, Nazia Selzner, Mark S. Cattral, Suresh V Venkatachalapathy, Gonzalo Sapisochin, Adam Doyle, Ian D. McGilvray, Anand Ghanekar, Mamatha Bhat, Eberhard L. Renner, David R. Grant, Assaf Issachar
Publikováno v:
Transplantation. 103:2523-2530
Diabetes mellitus (DM) is said to adversely affect transplant outcomes. The aim of this study was to investigate the impact of pre-existing and new-onset DM on liver transplantation (LT) recipients.A single-center retrospective analysis of prospectiv
Autor:
Eberhard L. Renner, David M. Grant, Harold Atkins, Natasha Kekre, Mark S. Cattral, Andrzej Chruscinski, Andrea Kew, Anne Marie Clement, Mitchell Sabloff, Kathryn Tinckham, David S. Allan, Robert B. Smith, Christopher Bredeson, Oyedele Adeyi, Anthony J. Demetris, Tae Kyoung Kim, Jianhua Zhang, Leslie B. Lilly, Atul Humar, Meaghan Macarthur, Sultan Altouri, S. Moshkelgosha, Isabelle Bence-Bruckler, Paul D. Greig, Stephen C. Juvet, Nazia Selzner, Tae Joon Yi, Anand Ghanekar, Korosh Khalili, Ian D. McGilvray, Gonzalo Sapisochin, Lisa Martin, Zita Galvin, Maor Epstein, Lothar Huebsch, Sandra Fischer, Jill Fulcher, Sheryl McDiarmid, Markus Selzner, Gary A. Levy
Publikováno v:
Transplantation. 106(3)
Background Primary sclerosing cholangitis (PSC) is an indication for liver transplantation, but recurrence after liver transplantation is associated with poor outcomes often requiring repeat transplantation. We investigated whether autologous hematop
Autor:
Sean P. Cleary, Mark S. Cattral, Eberhard L. Renner, David R. Grant, Anand Ghanekar, Nazia Selzner, Hala Muaddi, Markus Selzner, Oleg Mironov, Wei Zhang, Paul D. Greig, Assaf Issachar, R. Beecroft, Gonzalo Sapisochin, Morris Sherman, Aloysious Aravinthan, John R. Kachura, Leslie B. Lilly, Andre Gorgen, Adam Doyle, Ian D. McGilvray
Publikováno v:
Journal of Hepatology. 70:866-873
Radiofrequency ablation (RFA) is an effective treatment for single hepatocellular carcinoma (HCC) ≤3 cm. Disease recurrence is common, and in some patients will occur outside transplant criteria. We aimed to assess the incidence and risk factors fo